发明名称 BIOMARKER FOR LIVER CIRRHOSIS AND USAGES THEREOF
摘要 The faecal microbial communities and their functional composition are characterized by a whole gut microbiome-wild association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls. Veillonella atypical ACS-134-V-Col7a is enriched in liver cirrhosis patients while Bacteroides uniformis ATCC 8492 and Clostridiales are enriched in controls. A biomarker for liver cirrhosis in human comprises Veillonella atypical ACS-134-V-Col7a and at least one bacterial strain over-represented in gut microbiota of healthy subject as compared to liver cirrhosis affected subjects, which comprises Bacteroides uniformis ATCC 8492 and Clostridiales. Veillonella atypical ACS-134-V-Col7a, Bacteroides uniformis ATCC 8492 and Clostridiales would be used for treating/preventing or diagnosing liver cirrhosis.
申请公布号 WO2016008081(A1) 申请公布日期 2016.01.21
申请号 WO2014CN82181 申请日期 2014.07.15
申请人 ZHEJIANG UNIVERSITY 发明人 LI, LANJUAN;QIN, NAN
分类号 C12Q1/10;A61K35/74;A61P1/16;C12Q1/68 主分类号 C12Q1/10
代理机构 代理人
主权项
地址